The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 28, 2017

Filed:

Aug. 13, 2012
Applicants:

Anton Peter Jacob Middelberg, Brookfield, AU;

Linda Hwee-lin Lua, South Brisbane, AU;

Inventors:

Anton Peter Jacob Middelberg, Brookfield, AU;

Linda Hwee-Lin Lua, South Brisbane, AU;

Assignee:

University of Queensland, Queensland, AU;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/315 (2006.01); A61K 39/09 (2006.01); A61K 39/145 (2006.01); A61K 39/155 (2006.01); A61K 39/21 (2006.01); C12N 15/62 (2006.01); A61K 9/107 (2006.01); A61K 9/51 (2006.01); A61K 39/12 (2006.01); C07K 14/005 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/315 (2013.01); A61K 9/1075 (2013.01); A61K 9/5184 (2013.01); A61K 39/09 (2013.01); A61K 39/092 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); A61K 39/155 (2013.01); A61K 39/21 (2013.01); C07K 14/005 (2013.01); C12N 15/62 (2013.01); A61K 2039/523 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55566 (2013.01); C12N 2710/22022 (2013.01); C12N 2710/22043 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/18234 (2013.01);
Abstract

The present invention provides compositions relating to viral capsomeres which comprise foreign immunogenic sequences for use in pharmaceutical compositions and methods of producing such compositions, and related isolated or purified protein and nucleic acid molecules, vectors, host cells, compositions, and methods of use to augment an immune response, immunize an animal and prophylactically or therapeutically treat a disease, disorder or condition. The viral capsomere may be derived from a polyomavirus and comprise an immunogen of interest at the N-terminus and further at the C-terminus and/or at one or more exposed loops of the capsomere.


Find Patent Forward Citations

Loading…